Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja UBC Medical Indonesia Tbk. (LABS) vs Lippo Karawaci Tbk. (LPKR)

UBC Medical Indonesia Tbk.Trading
Lippo Karawaci Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan UBC Medical Indonesia Tbk. dan Lippo Karawaci Tbk.: UBC Medical Indonesia Tbk. diperdagangkan di Rp148 (kapitalisasi pasar 576,7 M, volume 24 jam 3,48 jt), sedangkan Lippo Karawaci Tbk. diperdagangkan di Rp63 (kapitalisasi pasar 4,25 T, volume 24 jam 148,64 jt). Perbedaan utamanya: Lippo Karawaci Tbk. jauh lebih besar — sekitar 7,4× kapitalisasi pasar UBC Medical Indonesia Tbk., dan Lippo Karawaci Tbk. lebih aktif diperdagangkan (148,64 jt vs 3,48 jt). Mana yang lebih baik tergantung tujuan investasimu.

LABSLPKR
Kapitalisasi Pasar
576,7 M4,25 T
Volume
3,48 jt148,64 jt
Lot
34,82 rb1,49 jt
Perputaran
522,79 jt9,21 M
Harga Rata-rata
150,1361,95
Nilai Transaksi
522,79 jt9,21 M
Harga Ekuilibrium Indikatif
14863
Volume Ekuilibrium Indikatif
35018,08 rb

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

LABS
Lihat detail
LPKR
Lihat detail

Tentang UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Selengkapnya di halaman LABS

Tentang Lippo Karawaci Tbk.

PT Lippo Karawaci Tbk was established under the name of PT Tunggal Reksakencana on October, 1990. The Company's scope of activities includes real estate, urban development and infrastructure, industrial estate development, general facilities and infrastructure development, services and investments, both direct and indirect, either through its subsidiaries or in joint venture with other parties.

Selengkapnya di halaman LPKR